Aston University collaboration to develop injectable paste which could treat bone cancer
Grant and Award Announcement
Updates every hour. Last Updated: 15-May-2025 04:09 ET (15-May-2025 08:09 GMT/UTC)
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering technique developed by researchers at UCL and the Francis Crick Institute.
In a landmark review published in Brain Medicine, Professor Hyman M. Schipper maps out the complex interactions between reproductive hormones and neurological health. This comprehensive analysis examines how sex hormones influence various conditions including migraine, stroke, movement disorders, epilepsy, and multiple sclerosis. The review highlights emerging evidence on neurosteroid pathways and suggests potential therapeutic applications, while emphasizing the importance of considering hormonal factors in neurological care.
University of Chicago researchers analyzed data to identify trends that could shed light on why Black women with triple-negative breast cancer (TNBC) have worse survival rates. Since new immunotherapy treatments for metastatic and early-stage TNBC were approved in 2019 and 2021, Howard and Freeman also examined disparities in access to these new treatments. While they found that much of the inequality they observed between racial and ethnic groups could be explained by socioeconomic disparities, they also found that Black women with TNBC were less likely to receive immunotherapy treatment even when accounting for those factors.
Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge that has long been limited by the protective nature of the blood-brain barrier. The findings, in mouse models and isolated human brain tissue, were published in the February 17 online issue of Nature Materials. They demonstrate the potential of this technology to pave the way for future treatments for a wide range of conditions such as Alzheimer’s disease, amyotrophic lateral sclerosis, brain cancer, and drug addiction.